TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
21/10/2025
Voltar para busca
Dado oficial do USPTO
BIOHM
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
53
Atualização mais recente
26/10/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5
Data de depósito
20/12/2016
Data de registro
31/07/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
02/01/2025
Última transação
26/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
702
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
01/03/2017
Primeiro uso no comércio
01/03/2017
Código do desenho
4
Tipo de titular
99
Localização do titular
CLEVELAND, OH
Examinador
STINSON,JENNIFER ELLE
Localização atual
Historical data usage
Titulares e representantes
Titulares
BIOHM HEALTH INC.
BIOHM HEALTH LLC
PathoBiome LLC
Representantes
Lisa C. Pavento Meunier Carlin & Curfman LLC
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Probiotic supplements; vitamin and mineral supplements; vitamin supplements; whey protein supplements; dietary supplement drink mixes; dietary supplement for eliminating toxins from the intestinal tract; enzyme food supplements; herbal supplements; mineral supplements; multi-vitamin preparations; natural herbal supplements; nutraceuticals for use as a dietary supplement; nutritional supplement for eliminating toxins from the intestinal tract; nutritional supplement shakes; nutritional supplementsprobiotic compositions; nutritional supplementscarbohydrates in powdered form; powdered nutritional supplement concentrate; vitamin and mineral supplements in powdertabletliquidcapsule or spray form; mineral supplements in powdertabletliquidcapsule or spray form; dietary supplements in powdertabletliquidcapsule or spray form; food supplements providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powdertabletliquidcapsule or spray form; nutritional supplements for human consumption providing a source of vitamins and minerals and essential fatty acids and probiotic cultures in powdertabletliquidcapsule or spray form; herbal supplements for general health and well-beingin powdertabletliquidcapsule or spray form; nutritional supplementsprobiotic compositions in the nature of a vaginal probiotic for the treatment and prevention of bacterial and fungal vaginal infection; nutraceuticals for the treatment and prevention of bacterial vaginosisvaginal discharge and odorsfor preventing the growth of undesirable micro-organisms that can cause vaginal discharge and odorkilling bacteria that cause bacterial vaginosisfor maintaining a desirable microflora in the vaginal cavity; micro-organisms culture for medical uselactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical products containing micro-organisms cultureslactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colon; pharmaceutical productsprobiotic lactic acid bacteriaprobiotic bifidobacteria which are able to ferment and use the fibres in the human organism for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colondietary and nutritional supplements containing microorganisms and cultures of microorganismsprobiotic lactic acid bacteriaprobiotic bifidobacteria which are able to ferment and use the fibres in the human organism; pharmaceutical products for oral consumptioncapsulestabletssolutionssuspensionsgranulespellets in dried formcontaining micro-organisms cultureslactic acid bacteria and bifidobacteria having probiotic activity on humans for the treatment of diseasesintestinal disordersdiarrhea and to re-equilibrate the intestinal bacterial florafor the treatment of intestinal inflammationsinflammatory bowel diseases and inflammations of the lower gastrointestinal tractfor the treatment of ulcerative colitis and crohn's disease in which inflammation is present both in the small intestine and in the colondietary and nutritional supplements for oral consumptioncapsulestabletssolutionssuspensionsgranulespellets in dried formcontaining micro-organisms cultureslactic acid bacteria and bifidobacteria having probiotic activity on humans; microbial and biological preparations for medical use for improving the physical well-being of humansreducing inflammation and pain; dietary supplements for medical usebaby foodall the above containing preparations and products resulting from the processing of microorganismsparticularly metabolites obtained from the processing of probiotic bacterial cultures; probiotic and nutritional and dietary supplements; antifungal preparations; antifungal creams for medical use; vaginal antifungal preparations; fungal and bacterial probiotic supplementsnutritional supplement for digestive health; nutritional supplement for combating digestive disorders such as Crohn's Diseaseulcerative colitis and irritable bowel syndrome
Publicações
Histórico de despachos e eventos da marca no USPTO.
53 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
21/10/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
21/10/2025
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
02/01/2025
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
02/01/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
31/12/2024
E815
TEAS SECTION 8 & 15 RECEIVED
31/07/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
31/07/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
15/02/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
22/11/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
22/11/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
22/11/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22/11/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22/11/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
22/11/2020
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
30/01/2019
R.PR
REGISTERED-PRINCIPAL REGISTER
31/07/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
26/06/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
25/06/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
31/05/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
31/05/2018
IUAF
USE AMENDMENT FILED
09/05/2018
EISU
TEAS STATEMENT OF USE RECEIVED
09/05/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/05/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
06/03/2018
PUBO
PUBLISHED FOR OPPOSITION
06/03/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
14/02/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
31/01/2018
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/11/2017
GNSL
LETTER OF SUSPENSION E-MAILED
04/11/2017
CNSL
SUSPENSION LETTER WRITTEN
04/11/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
17/10/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
17/10/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
16/10/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
25/09/2017
GNRT
NON-FINAL ACTION E-MAILED
25/09/2017
CNRT
NON-FINAL ACTION WRITTEN
25/09/2017
RMRF
REMOVE FROM TEASRF
25/09/2017
ACEC
AMENDMENT FROM APPLICANT ENTERED
30/08/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
30/08/2017
ALIE
ASSIGNED TO LIE
28/08/2017
PAPER RECEIVED
08/08/2017
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
17/07/2017
GNSL
LETTER OF SUSPENSION E-MAILED
17/07/2017
CNSL
SUSPENSION LETTER WRITTEN
17/07/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/06/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/06/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/06/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
27/03/2017
GNRT
NON-FINAL ACTION E-MAILED
27/03/2017
CNRT
NON-FINAL ACTION WRITTEN
27/03/2017
DOCK
ASSIGNED TO EXAMINER
21/03/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/12/2016
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIOHM ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.